Code | 64994 | ||||||||||
MA number | EU/1/98/063/009 | ||||||||||
Product Form: | sol inj 4x1,5 ml/132 µg (náplň skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Merck Europe B.V., Netherland | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 18 | ||||||||||
Route of admin.: | Subcutaneous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application |
MA issued: | 16.01.2009 |
SmPC + PL: | European Medicines Agency's database |
Dokument: | DHPC interferóny final 25 8 2014.pdf |
Safety feature | Yes |
Data update: | 19.06.2018 |